ICD-10-PCS 2027 procedure code
XW0DXJ9Introduction of Quizartinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 9
Short description: Introduce Quizartinib in Mouth/Phar, Extern, New Tech 9
Code last changed in FY2024 (effective October 1, 2023). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data
About XW0DXJ9
XW0DXJ9 is the ICD-10-PCS code for a introduction procedure on the mouth and pharynx using an external approach with quizartinib antineoplastic (qualifier: new technology group 9). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
With a different device, use XW0DXN9 (SER-109).
It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.
It was added in FY2024, effective October 1, 2023.
What each character means
- 1. Section
- XNew Technology
- 2. Body System
- WAnatomical Regions
- 3. Operation
- 0Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
- 4. Body Part
- DMouth and Pharynx
- 5. Approach
- XExternal
Procedures performed directly on the skin or mucous membrane and procedures performed indirectly by the application of external force through the skin or mucous membrane
- 6. Device / Substance / Technology
- JQuizartinib Antineoplastic
- 7. Qualifier
- 9New Technology Group 9
Other versions of this procedure
Different device / substance / technology
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2024 (effective 10/1/2023): Added
- No changes since FY2024.
Common questions about XW0DXJ9
Is XW0DXJ9 a valid ICD-10-PCS code for 2027?
- Yes. XW0DXJ9 is valid for inpatient procedures from October 1, 2026 through September 30, 2027.